Results 51 to 60 of about 42,534 (266)

HIV‐1 Integrase Inhibition of Biscoumarin Analogues.

open access: yesChemInform, 2006
AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
Chang-Xiao, Su   +4 more
openaire   +3 more sources

Uneven Genetic Robustness of HIV-1 Integrase [PDF]

open access: yesJournal of Virology, 2015
ABSTRACT Genetic robustness (tolerance of mutation) may be a naturally selected property in some viruses, because it should enhance adaptability. Robustness should be especially beneficial to viruses like HIV-1 that exhibit high mutation rates and exist in immunologically hostile environments.
Suzannah J, Rihn   +3 more
openaire   +2 more sources

Nucleolar Localization of HIV-1 Rev Is Required, Yet Insufficient for Production of Infectious Viral Particles. [PDF]

open access: yes, 2018
Combination antiretroviral therapy fails in complete suppression of HIV-1 due to drug resistance and persistent latency. Novel therapeutic intervention requires knowledge of intracellular pathways responsible for viral replication, specifically those ...
Arizala, Jerlisa Ann C   +5 more
core   +1 more source

Characterization of HIV-1 integrase interaction with human Ku70 protein and initial implications for drug targeting

open access: yesScientific Reports, 2017
Human Ku70/Ku80 protein is known to influence HIV-1 replication. One of the possible reasons may be the protection of integrase from proteasomal degradation by Ku70 subunit. We demonstrated that recombinant HIV-1 integrase and Ku70 form a stable complex,
Andrey N. Anisenko   +6 more
doaj   +1 more source

HIV-1 Infection Requires a Functional Integrase NLS [PDF]

open access: yesMolecular Cell, 2001
HIV-1 is able to infect nondividing cells productively in part because the postentry viral nucleoprotein complexes are actively imported into the nucleus. In this manuscript, we identify a novel nuclear localization signal (NLS) in the viral integrase (IN) protein that is essential for virus replication in both dividing and nondividing cells.
Bouyac-Bertoia, M   +7 more
openaire   +3 more sources

Resistance to inhibitors of the human immunodeficiency virus type 1 integration

open access: yesBrazilian Journal of Infectious Diseases
This review will summarize the role of integrase in HIV-1 infection, the mechanism of integrase inhibitors and resistance with an emphasis on raltegravir (RAL), the first integrase inhibitor licensed to treat HIV-1 ...
Daria J Hazuda
doaj   +1 more source

Docking and Molecular Dynamics Calculations of Some Previously Studied and newly Designed Ligands to Catalytic Core Domain of HIV-1 Integrase and an Investigation to Effects of Conformational Changes of Protein on Docking Results

open access: yesJournal of the Turkish Chemical Society, Section A: Chemistry, 2016
Nowadays, AIDS still remains as a worldwide pandemic and continues to cause many death which arise from HIV-1 virus. For nearly 35 years, drugs that target various steps of virus life cycle have been developed.
Selami Ercan
doaj   +1 more source

Urinary eicosanoid metabolites in HIV-infected women with central obesity switching to raltegravir: an analysis from the women, integrase, and fat accumulation trial. [PDF]

open access: yes, 2014
Chronic inflammation is a hallmark of HIV infection. Eicosanoids reflect inflammation, oxidant stress, and vascular health and vary by sex and metabolic parameters. Raltegravir (RAL) is an HIV-1 integrase inhibitor that may have limited metabolic effects.
Boger, M Sean   +11 more
core   +3 more sources

Synthesis of New Potential HIV-1 Integrase Inhibitors [PDF]

open access: yesHETEROCYCLES, 2004
AbstractFor Abstract see ChemInform Abstract in Full Text.
FERRO, Stefania   +7 more
openaire   +4 more sources

Molecular mechanisms of retroviral integration site selection [PDF]

open access: yes, 2015
Retroviral replication proceeds through an obligate integrated DNA provirus, making retroviral vectors attractive vehicles for human gene-therapy. Though most of the host cell genome is available for integration, the process of integration site selection
Engelman, Alan   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy